Current and future status of proton-beam radiation therapy in radiation oncology

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 4, 2007, Pages 303-305

  Cox, James ^a,b  

^a Division of Radiation Oncology   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RISK; CARTILAGE TUMOR; CHILD HEALTH CARE; CHONDROSARCOMA; CHORDOMA; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DOSIMETRY; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MEDULLOBLASTOMA; METASTASIS; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RISK ASSESSMENT; RISK REDUCTION; SKULL BASE TUMOR; TREATMENT INDICATION; TUMOR VOLUME; UNITED STATES; UVEA MELANOMA;

FORECASTING; HUMANS; MELANOMA; PROTONS; RADIOTHERAPY DOSAGE; UVEAL NEOPLASMS;

EID: 34249026657     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Chang JY, Zhang X, Wang X, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 200;65:1087-1096.
2. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 200;63:362-372.
3. MacDonald SM, DeLaney TF, Loeffler JS. Proton beam radiation therapy. Cancer Invest. 2006;24:199-208.
4. Glimellus B, Isacsson U, Blomquist E, et al. Potential gains using high-energy protons for therapy of malignant turnouts. Acta Oncologica. 1999;38:137-145.